Provention Bio Analysis
PRVBDelisted Stock | USD 24.98 0.00 0.00% |
Provention Bio is overvalued with Real Value of 17.35 and Hype Value of 24.98. The main objective of Provention Bio delisted stock analysis is to determine its intrinsic value, which is an estimate of what Provention Bio is worth, separate from its market price. There are two main types of Provention Bio's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Provention Bio's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Provention Bio's stock to identify patterns and trends that may indicate its future price movements.
The Provention Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Provention Bio is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Provention Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Provention Bio's ongoing operational relationships across important fundamental and technical indicators.
Provention |
Provention Stock Analysis Notes
About 53.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.52. Provention Bio had not issued any dividends in recent years. Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Provention Bio, Inc. was incorporated in 2016 and is headquartered in Red Bank, New Jersey. Provention Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people. To find out more about Provention Bio contact Ashleigh Palmer at 908 336 0360 or learn more at https://www.proventionbio.com.Provention Bio Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Provention Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Provention Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Provention Bio is not yet fully synchronised with the market data | |
Provention Bio has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 12.89 M. Net Loss for the year was (113.56 M) with loss before overhead, payroll, taxes, and interest of (63.42 M). | |
Provention Bio currently holds about 84.52 M in cash with (75.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.04. |
Provention Bio Upcoming and Recent Events
Earnings reports are used by Provention Bio to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Provention Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of May 2023 Upcoming Quarterly Report | View | |
3rd of August 2023 Next Financial Report | View | |
31st of March 2023 Next Fiscal Quarter End | View | |
3rd of April 2024 Next Fiscal Year End | View | |
31st of December 2022 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Provention Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.38 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Provention Bio's market, we take the total number of its shares issued and multiply it by Provention Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Provention Bio Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Provention Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Provention Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Provention Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sessa Capital Master Lp over six months ago Disposition pursuant to a tender of shares in a change of control transaction by Sessa Capital Master Lp of Provention Bio | ||
Sessa Capital Master Lp over a year ago Provention Bio exotic insider transaction detected | ||
Sessa Capital Master Lp over a year ago Exercise of in-the-money or at-the-money derivative position by Sessa Capital Master Lp of 8879023 shares of Provention Bio | ||
Francisco Leon over a year ago Bona fide gift to Francisco Leon of 1500000 shares of Provention Bio subject to Section 16 |
Provention Bio Predictive Daily Indicators
Provention Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Provention Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Provention Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Provention Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Provention shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Provention Bio. By using and applying Provention Stock analysis, traders can create a robust methodology for identifying Provention entry and exit points for their positions.
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Provention Bio, Inc. was incorporated in 2016 and is headquartered in Red Bank, New Jersey. Provention Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Provention Bio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Provention Stock
If you are still planning to invest in Provention Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provention Bio's history and understand the potential risks before investing.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |